These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 11201137

  • 1. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T.
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [Abstract] [Full Text] [Related]

  • 2. [Desensitization therapy for antituberculous drugs].
    Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T.
    Kekkaku; 2000 Sep; 75(9):521-6. PubMed ID: 11068368
    [Abstract] [Full Text] [Related]

  • 3. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [Abstract] [Full Text] [Related]

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 5. [A case of successful desensitization therapy for isoniazid-induced pneumonitis].
    Nishizawa Y, Yasui M, Yamamori C, Tagami A, Fujimura M, Nakao S.
    Nihon Kokyuki Gakkai Zasshi; 2004 Jul; 42(7):649-54. PubMed ID: 15357268
    [Abstract] [Full Text] [Related]

  • 6. [Management of adverse effects with antituberculosis chemotherapy].
    Tsuyuguchi K, Wada M.
    Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
    [Abstract] [Full Text] [Related]

  • 7. [Anti-tuberculosis chemotherapy and management of adverse reactions].
    Kuwabara K.
    Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E, Suzuki T, Tagawa K, Takahara M, Ito M, Arai T, Kabe J, Baba H.
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y, Okimoto N, Matsushima T, Shigetou E, Kuraoka T, Takeyama H, Eda R, Yano S, Kobayashi K, Ohnishi T, Mori K, Ueda Y, Moritaka T, Nishimura K, Abe T.
    Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
    [Abstract] [Full Text] [Related]

  • 13. [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
    Kuroda F, Yagi T, Yamagishi F, Mizutani F, Sasaki Y, Wada A.
    Kekkaku; 1999 Nov; 74(11):803-7. PubMed ID: 10599213
    [Abstract] [Full Text] [Related]

  • 14. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
    Shigeto E, Murakami I, Yokosaki Y.
    Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M, Nakajima Y.
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [Abstract] [Full Text] [Related]

  • 16. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y, Nagayama N, Kawabe Y, Shimada M, Suzuki J, Kunogi M, Matsui Y, Kawashima M, Suzuki J, Ariga H, Oshima N, Masuda K, Matsui H, Nagai H, Tamura A, Akagawa S, Toyoda E, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [Abstract] [Full Text] [Related]

  • 17. [The effectiveness of steroid as adjunctive therapy in the management of two patients with febrile reaction due to antituberculous drugs].
    Yano S, Kobayashi K, Kawasaki Y, Kato K, Saito S.
    Kekkaku; 2001 Sep; 76(9):635-9. PubMed ID: 11676121
    [Abstract] [Full Text] [Related]

  • 18. [Clinical study on the cases in which INH or RFP was discontinued during treatment for pulmonary tuberculosis].
    Harada S, Takamoto M, Ishibashi T, Mohri M, Sato K, Yamagishi F, Sasaki Y, Tanabe K, Sato R, Fujino T, Tano M, Tanizawa M, Sakatani M, Morimoto T, Kawahara S, Hotta N, Shigeto E, Nishimura K, Abe T, Iwanaga T, Oe T, Shimazu K, Ebihara M, Nakagawa S, Kuba M, Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS).
    Kekkaku; 2001 May; 76(5):427-36. PubMed ID: 11449698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Adverse reactions of antituberculous agents, especially about its onset and duration].
    Yamada H, Yasuoka A, Sasayama K, Doutsu Y, Hayashi T, Kohno S, Yamaguchi K, Hirota M, Hara K.
    Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.